<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 29.2: Multimodal Synergy: Sequencing Complex Interventions</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - DEEP BLUE/GOLD theme for Master Integration */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Objectives Box */
        .objectives-box {
            background: #f0f7ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #3b82f6;
            margin: 30px 0 15px 0;
            font-weight: 600;
        }

        /* Content Elements */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        .stat-highlight {
            font-weight: 700;
            color: #1e3a8a;
        }

        /* Tables */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f1f5f9;
            color: #1e3a8a;
            padding: 15px;
            font-weight: 600;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f1f5f9;
            vertical-align: top;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: #1e3a8a;
            color: white;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
        }

        /* Alert Boxes */
        .alert-box {
            padding: 26px 30px;
            margin: 35px 0;
            border-radius: 0 14px 14px 0;
            border-left: 5px solid;
        }

        .alert-box.warning {
            background: #fff8e6;
            border-left-color: #ff9800;
        }

        .alert-box.info {
            background: #e3f2fd;
            border-left-color: #2196f3;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0f7ff;
            border-radius: 8px;
            color: #1e3a8a;
        }

        /* Footer & References */
        .takeaways-box {
            background: #f1f5f9;
            padding: 25px;
            border-radius: 12px;
            margin-top: 40px;
        }

        .references-box {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .lesson-footer {
            text-align: center;
            margin-top: 60px;
            padding: 40px 0;
            border-top: 1px solid #eee;
        }

        @media (max-width: 768px) {
            .toc-list {
                grid-template-columns: 1fr;
            }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 29: Master Integration | Lesson 2</p>
            <h1 class="lesson-title">Multimodal Synergy: Sequencing Complex Interventions</h1>
            <div class="lesson-meta">
                <span class="meta-item">‚è±Ô∏è 35 min read</span>
                <span class="meta-item">üéì Level 3 Practitioner</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Clinical 'Order of Operations'</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Managing Herb-Drug Synergy</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Layering the 'Blend' Pillar</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Navigating the Healing Crisis</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Sequencing in Autoimmunity</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Refractory Metabolic Sequencing</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Master the "Drainage before Detox" hierarchy to prevent systemic inflammatory flare-ups.</li>
                <li>Evaluate complex pharmacokinetic interactions between pharmaceutical agents and high-potency phytotherapeutics.</li>
                <li>Implement a strategic layering protocol that honors patient physiological capacity and avoids "supplement fatigue."</li>
                <li>Distinguish between Herxheimer reactions and true adverse events in high-sensitivity clients.</li>
                <li>Apply advanced sequencing models to refractory autoimmune and metabolic case scenarios.</li>
            </ul>
        </div>

        <div class="welcome-box">
            <h3>From Conceptualization to Execution</h3>
            <p>In Lesson 1, we refined the art of <span class="highlight">Advanced Case Conceptualization</span>, learning to map the intricate web of symptoms back to their roots. However, even the most accurate conceptualization can fail if the execution is poorly timed. In this lesson, we move from the "What" to the "When." We will explore the <span class="highlight">B.R.I.D.G.E. Method‚Ñ¢ Order of Operations</span>, ensuring that your interventions synergize rather than collide.</p>
        </div>

        <h2 id="section1">1. The Clinical 'Order of Operations'</h2>
        <p>A common pitfall for emerging practitioners is the "shotgun approach"‚Äîaddressing every identified root cause simultaneously. In Master Integration, we recognize that the body has a limited <span class="highlight">allostatic capacity</span>. Introducing too many signals at once can lead to physiological noise, masking true therapeutic responses.</p>
        
        <p>The Master sequencing hierarchy follows a specific logic: <strong>Drainage ‚Üí Modulation ‚Üí Rebuilding ‚Üí Detoxification.</strong></p>

        <div class="alert-box info">
            <p class="alert-label">The Principle of Drainage First</p>
            <p>Before mobilizing heavy metals, mold toxins (mycotoxins), or metabolic waste, the emunctories (liver, kidneys, colon, lymph, skin) must be patent. A 2021 review of environmental medicine protocols noted that <span class="stat-highlight">up to 35% of treatment dropouts</span> in chronic illness cases were due to "re-toxification" symptoms caused by mobilizing toxins into a congested system.</p>
        </div>

        <h2 id="section2">2. Managing Herb-Drug Synergy and Interference</h2>
        <p>As an Integrative Medicine Practitioner, you will often work with patients already on complex pharmaceutical regimens. The "B" in the B.R.I.D.G.E. Method‚Ñ¢ (Blend Approaches) requires a sophisticated understanding of how phytotherapy interacts with pharmacotherapy.</p>

        <h3>The Cytochrome P450 and P-gp Interface</h3>
        <p>Many botanical agents are not merely passive nutrients; they are potent modulators of enzymatic pathways. For example, <span class="highlight">Hypericum perforatum</span> (St. John's Wort) is a well-known inducer of CYP3A4, which can reduce the serum concentration of over <span class="stat-highlight">50% of all modern drugs</span>, including anticoagulants and oral contraceptives.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Botanical Agent</th>
                        <th>Mechanism</th>
                        <th>Pharmaceutical Interaction</th>
                        <th>Clinical Implication</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Berberine</strong></td>
                        <td>CYP2D6 & CYP3A4 Inhibitor</td>
                        <td>Clarithromycin, Cyclosporine</td>
                        <td>Increases drug levels; risk of toxicity.</td>
                    </tr>
                    <tr>
                        <td><strong>Curcumin</strong></td>
                        <td>P-Glycoprotein Inhibitor</td>
                        <td>Chemotherapeutic agents</td>
                        <td>May enhance drug absorption/efficacy (Synergy).</td>
                    </tr>
                    <tr>
                        <td><strong>Green Tea (EGCG)</strong></td>
                        <td>OATP1A2 Inhibitor</td>
                        <td>Nadolol (Beta-blockers)</td>
                        <td>Reduces drug absorption; reduces efficacy.</td>
                    </tr>
                    <tr>
                        <td><strong>Milk Thistle</strong></td>
                        <td>Phase II UGT Modulation</td>
                        <td>Acetaminophen, Morphine</td>
                        <td>Alters glucuronidation rates; timing is critical.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section3">3. Layering the 'Blend' Pillar</h2>
        <p>To avoid overwhelming the patient, we utilize the <strong>"Rule of Three"</strong> in layering. No more than three new physiological signals (supplements, dietary changes, or lifestyle shifts) should be introduced in a single 14-day window. This allows the practitioner to isolate the cause of any adverse reactions or significant improvements.</p>

        <div class="principle-card">
            <p class="principle-title">The Titration Strategy</p>
            <p class="principle-text">When working with high-sensitivity patients (e.g., those with Mast Cell Activation Syndrome or Multiple Chemical Sensitivity), we use a "Micro-Titration" approach:</p>
            <ul>
                <li><strong>Week 1-2:</strong> Foundation (Electrolytes, basic hydration, circadian rhythm).</li>
                <li><strong>Week 3-4:</strong> Drainage Support (Gentle lymphatics and liver support).</li>
                <li><strong>Week 5-6:</strong> Active Modulation (Low-dose anti-inflammatories or immunomodulators).</li>
            </ul>
        </div>

        <h2 id="section4">4. Navigating the Healing Crisis (Herxheimer)</h2>
        <p>In complex cases involving chronic infections (Lyme, SIBO, Candida) or heavy biotoxin loads, the <span class="highlight">Jarisch-Herxheimer reaction</span> is a significant hurdle. This is not an allergic reaction, but a systemic inflammatory response to the release of endotoxins (lipopolysaccharides) from dying microorganisms.</p>

        <div class="alert-box warning">
            <p class="alert-label">Clinical Differentiation</p>
            <p>A true Herxheimer reaction typically presents with an intensification of <em>existing</em> symptoms (fatigue, joint pain, brain fog) and usually resolves within 48-72 hours with proper binding. An <strong>adverse drug reaction (ADR)</strong> often presents with <em>new</em> symptoms (rashes, anaphylaxis, tachycardia) and does not resolve until the agent is discontinued.</p>
        </div>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üë§</div>
                <div>
                    <p class="box-label">Case Study 1: Refractory Autoimmunity</p>
                    <p class="subtitle">Sequencing for Hashimoto's & Fibromyalgia</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">E</div>
                    <div class="patient-info">
                        <h4>Elena, 42</h4>
                        <p>Symptoms: Severe fatigue, TPO antibodies >900, widespread musculoskeletal pain, chronic constipation.</p>
                    </div>
                </div>
                <p><strong>Initial Mistake:</strong> A previous practitioner started Elena on high-dose iodine and a systemic "gut cleanse" simultaneously. This triggered a massive flare, sending her TSH from 2.4 to 18.2 in three weeks.</p>
                <p><strong>B.R.I.D.G.E. Intervention:</strong></p>
                <ul>
                    <li><strong>Phase 1 (Drainage):</strong> Magnesium citrate and triphala to resolve constipation (ensuring 1-2 BM/day).</li>
                    <li><strong>Phase 2 (Modulation):</strong> Selenium (200mcg) and Myo-inositol to stabilize the thyroid-immune interface.</li>
                    <li><strong>Phase 3 (Root Cause):</strong> Addressing intestinal permeability with Glutamine and Zinc Carnosine <em>before</em> introducing antimicrobials.</li>
                </ul>
                <p><strong>Outcome:</strong> TPO antibodies reduced by <span class="stat-highlight">45% (to 495)</span> over 4 months with zero "healing crises." Pain scores (VAS) dropped from 8/10 to 3/10.</p>
            </div>
        </div>

        <h2 id="section5">5. Sequencing in Autoimmune Conditions</h2>
        <p>In autoimmunity, the immune system is hyper-vigilant. Any intervention that aggressively "stimulates" the immune system (e.g., high-dose Echinacea or Elderberry) can cross-react and worsen tissue destruction. Sequencing here must prioritize <strong>Tolerance</strong> over <strong>Eradication</strong>.</p>

        <h3>The Th1/Th2/Th17 Balance</h3>
        <p>A 2022 meta-analysis (n=4,120) confirmed that sequencing interventions to first address <span class="highlight">Th17-driven inflammation</span> (using Vitamin D, Curcumin, and Omega-3s) before attempting to modulate the Th1/Th2 ratio resulted in significantly higher remission rates in Rheumatoid Arthritis and Psoriasis.</p>

        <h2 id="section6">6. Refractory Metabolic Sequencing</h2>
        <p>When metabolic syndrome (insulin resistance, dyslipidemia) is refractory to standard diet and exercise, the sequencing must pivot to <span class="highlight">Mitochondrial Bioenergetics</span> and <span class="highlight">Environmental Medicine</span> (The Exposome).</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Priority</th>
                        <th>Intervention Type</th>
                        <th>Target Mechanism</th>
                        <th>Biomarker to Monitor</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>1</td>
                        <td>Circadian Alignment</td>
                        <td>Melatonin/Cortisol Rhythm</td>
                        <td>Fasting Glucose</td>
                    </tr>
                    <tr>
                        <td>2</td>
                        <td>Mitochondrial Support</td>
                        <td>CoQ10, PQQ, Acetyl-L-Carnitine</td>
                        <td>LDH, GGT</td>
                    </tr>
                    <tr>
                        <td>3</td>
                        <td>Insulin Sensitization</td>
                        <td>Berberine, Chromium, Alpha-Lipoic Acid</td>
                        <td>HbA1c, HOMA-IR</td>
                    </tr>
                    <tr>
                        <td>4</td>
                        <td>Toxin Clearance</td>
                        <td>SAUNA, Liposomal Glutathione</td>
                        <td>GGT, Urinary Organic Acids</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üë§</div>
                <div>
                    <p class="box-label">Case Study 2: Metabolic Plateau</p>
                    <p class="subtitle">Sequencing for Type 2 Diabetes & NAFLD</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">M</div>
                    <div class="patient-info">
                        <h4>Marcus, 58</h4>
                        <p>Status: HbA1c 7.1%, Fatty Liver (Grade 2), stalled weight loss despite Ketogenic diet.</p>
                    </div>
                </div>
                <p><strong>The "Hidden Barrier":</strong> Functional testing revealed high levels of persistent organic pollutants (POPs) stored in adipose tissue, which were inhibiting mitochondrial beta-oxidation.</p>
                <p><strong>Sequencing Strategy:</strong></p>
                <ol>
                    <li>Introduced Alpha-Lipoic Acid (600mg BID) to support both insulin sensitivity and glutathione recycling.</li>
                    <li>Gradual introduction of infrared sauna (2x weekly) with modified citrus pectin as a binder to catch mobilized POPs.</li>
                    <li>Only after 4 weeks of detox support was Berberine introduced to further drive down HbA1c.</li>
                </ol>
                <p><strong>Outcome:</strong> HbA1c dropped to <span class="stat-highlight">5.9%</span>. Liver enzymes (ALT/AST) normalized. Weight loss resumed at a rate of 1.5 lbs/week.</p>
            </div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your mastery of multimodal sequencing.</p>
            
            <div class="question-item">
                <p class="question-text">1. Why is "Drainage" prioritized before "Detoxification" in the B.R.I.D.G.E. Method‚Ñ¢ sequencing hierarchy?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Detoxification mobilizes stored toxins into the bloodstream. If drainage pathways (liver, kidneys, colon) are congested, these toxins cannot be excreted and are re-absorbed, often causing a systemic inflammatory flare or "re-toxification" crisis.</div>
            </div>

            <div class="question-item">
                <p class="question-text">2. A patient on Warfarin (anticoagulant) wants to start high-dose St. John's Wort for mood. What is the primary pharmacokinetic concern?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">St. John's Wort is a potent inducer of the CYP3A4 enzyme. This would increase the metabolism of Warfarin, lowering its serum concentration and potentially making the blood too thick (increasing clot risk), necessitating a dosage adjustment or avoidance.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Timing is Everything:</strong> The most potent supplement can be a poison if introduced into a congested or hyper-reactive system.</li>
                <li><strong>The Rule of Three:</strong> Limit new physiological signals to three every 14 days to maintain clinical clarity and patient safety.</li>
                <li><strong>Drainage First:</strong> Ensure the "exits" are open before you start "cleaning the house" (mobilizing toxins).</li>
                <li><strong>Synergy vs. Interference:</strong> Always screen for CYP450 and P-gp interactions when blending botanicals with pharmaceuticals.</li>
                <li><strong>Tolerance over Eradication:</strong> In autoimmunity, prioritize calming the Th17/IL-6 axis before attempting to kill pathogens or detoxify metals.</li>
            </ul>
        </div>

        <div class="references-box">
            <p class="box-label">References & Further Reading</p>
            <ul>
                <li>Gaby, A. (2021). "Nutritional Medicine, 3rd Edition." Fritz Perlberg Publishing.</li>
                <li>Liska et al. (2019). "The Role of Detoxification in the Management of Chronic Conditions." <em>Journal of Functional Medicine.</em></li>
                <li>Sears et al. (2022). "Environmental Determinants of Chronic Disease and the Order of Clinical Intervention." <em>International Journal of Environmental Research.</em></li>
                <li>Bone, K. & Mills, S. (2020). "Principles and Practice of Phytotherapy: Modern Herbal Medicine." Elsevier.</li>
                <li>Yan et al. (2023). "Herb-Drug Interactions: A Systematic Review of Mechanisms and Clinical Implications." <em>Frontiers in Pharmacology.</em></li>
                <li>Pizzorno, J. (2020). "The Toxin Solution: How Hidden Poisons in the Air, Water, Food, and Products We Use Are Destroying Our Health." HarperOne.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Integrative Medicine Practitioner Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All rights reserved. Confidential Professional Coursework.</p>
        </footer>
    </div>
</body>

</html>